Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Respiratory Medicine

Topics

Medicine

Pathology

Internal Medicine

Neurology

Molecular Biology

Show all topics

DOI

10.1016/s2213-2600(21)00222-8

License

CC-BY

Other Formats

PDF